These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4016671)

  • 1. Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
    Coon JS; McCall A; Miller AW; Farrow GM; Weinstein RS
    Cancer; 1985 Aug; 56(4):797-804. PubMed ID: 4016671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.
    Weinstein RS; Alroy J; Farrow GM; Miller AW; Davidsohn I
    Cancer; 1979 Feb; 43(2):661-8. PubMed ID: 421187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.
    Jakse G; Hofstädter F
    Urol Res; 1981; 9(3):153-6. PubMed ID: 7257030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of an assessment of ABH(0) isoantigens and Thomsen-Friedenreich (TF) antigen expression in patients with urinary bladder tumours.
    Dobrowolski ZF; Duś D; Hałasa J; Radzikowski C
    Int Urol Nephrol; 1995; 27(4):395-404. PubMed ID: 8586511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
    Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
    Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS; Weinstein RS; Summers JL
    Am J Clin Pathol; 1982 Jun; 77(6):692-9. PubMed ID: 7091049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS; Miller AW; Coon JS
    Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder.
    Malmström PU; Norlén BJ; Andersson B; Busch C
    Br J Urol; 1989 Jul; 64(1):49-55. PubMed ID: 2765768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ABH isoantigen of superficial urothelial tumor and carcinoma in situ of the bladder by the avidin-biotin peroxidase complex(ABC) method].
    Sasaki K
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1326-38. PubMed ID: 6374223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic factors for progression of superficial bladder cancer].
    Sato N; Sumiya H; Isaka S; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of ABH antigens in tumours of the bladder. A retrospective immunofluorescence study (author's transl)].
    Rouger P; Vallancien G; Leclerc JP; Gane P; Salmon C
    Nouv Presse Med; 1982 Feb; 11(6):419-21. PubMed ID: 7038622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of ABH antigens and CEA for the prognosis of urothelial tumors].
    Hofstädter F; Jakse G
    Wien Klin Wochenschr; 1982 Jul; 94(14):366-8. PubMed ID: 7147976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.